Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls
- PMID: 17605005
- DOI: 10.1007/s00213-007-0837-5
Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls
Abstract
Rationale: Despite years of research and much controversy surrounding the effects of ecstasy use, findings are equivocal. Attempting to reduce methodological problems, such as concurrent use of other recreational drugs, could lead to a clearer picture of the effects of ecstasy use on cognitive function.
Objectives: The aim of this study is to investigate the effects of both prolonged abstention from ecstasy use and current use on cognitive function while controlling for the regular use of other recreational drugs used by ecstasy users (alcohol, cannabis, cocaine, amphetamines and lysergic acid diethylamide).
Materials and methods: A range of cognitive functions (including working memory, episodic memory, verbal learning and executive functions) was assessed in 109 participants: 25 current ecstasy users, 28 ex-ecstasy users (abstinent for at least 1 year), 29 polydrug-using controls (matched to both ecstasy-using groups for the use of other recreational drugs) and 27 drug-naïve controls.
Results: There was an overall tendency for impaired verbal learning and memory in both current ecstasy users and polydrug controls. There was also evidence of reduced response inhibition in the current ecstasy users and polydrug controls, which appeared to be related to recency of drug use. However, the majority of tests showed no group differences.
Conclusions: The results suggest that recreational drug use in general, rather than ecstasy use per se, can lead to subtle cognitive impairments and that recent drug use appears to impact strongest on cognitive performance. This study highlights the importance of controlling for the use of all recreational drugs and, in particular, recent drug use when investigating 'effects of ecstasy' on cognitive function.
Similar articles
-
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21. J Psychopharmacol. 2008. PMID: 18208910
-
Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?Psychopharmacology (Berl). 2002 Jan;159(3):294-303. doi: 10.1007/s002130100907. Epub 2001 Oct 12. Psychopharmacology (Berl). 2002. PMID: 11862362
-
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):719-25. doi: 10.1136/jnnp.68.6.719. J Neurol Neurosurg Psychiatry. 2000. PMID: 10811694 Free PMC article.
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?Addiction. 2006 Mar;101(3):348-61. doi: 10.1111/j.1360-0443.2006.01314.x. Addiction. 2006. PMID: 16499508 Review.
Cited by
-
Clinical applications of hallucinogens: A review.Exp Clin Psychopharmacol. 2016 Aug;24(4):229-68. doi: 10.1037/pha0000084. Exp Clin Psychopharmacol. 2016. PMID: 27454674 Free PMC article. Review.
-
Altered visual perception in long-term ecstasy (MDMA) users.Psychopharmacology (Berl). 2013 Sep;229(1):155-65. doi: 10.1007/s00213-013-3094-9. Epub 2013 Apr 23. Psychopharmacology (Berl). 2013. PMID: 23609769 Clinical Trial.
-
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20. J Psychopharmacol. 2013. PMID: 23172889 Free PMC article. Clinical Trial.
-
Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.Neuropsychopharmacology. 2011 Mar;36(4):735-43. doi: 10.1038/npp.2010.201. Epub 2010 Dec 15. Neuropsychopharmacology. 2011. PMID: 21160467 Free PMC article.
-
Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences.Nordisk Alkohol Nark. 2021 Feb;38(1):35-49. doi: 10.1177/1455072520963787. Epub 2020 Oct 20. Nordisk Alkohol Nark. 2021. PMID: 35309094 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical